Due to its role in fibrosis and metabolic dysregulation associated with obesity and diabetes, we hypothesized that TSP-1 may be an important modulator in NAFLD/NASH. The gene discussed is THBS1; the disease is metabolic dysfunction-associated steatohepatitis.